Clinical Trial Search Results for "CLARITY-TIMI 28"

Ferguson, J. J. Clopidogrel plus aspirin in patients with acute myocardial infarction treated with fibrinolytic therapy--CLARITY-TIMI 28 Future Cardiol. 2005;1(5):605-10. Abstract

Sabatine, M. S., Cannon, C. P., Gibson, C. M., Lopez-Sendon, J. L., Montalescot, G., Theroux, P., Claeys, M. J., Cools, F., Hill, K. A., Skene, A. M., McCabe, C. H., Braunwald, E. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation N Engl J Med. 2005;352(12):1179-89.

Sabatine, M. S., Cannon, C. P., Gibson, C. M., Lopez-Sendon, J. L., Montalescot, G., Theroux, P., Lewis, B. S., Murphy, S. A., McCabe, C. H., Braunwald, E. Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study JAMA. 2005;294(10):1224-32.

Sabatine, M. S., McCabe, C. H., Gibson, C. M., Cannon, C. P. Design and rationale of Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 trial Am Heart J. 2005;149(2):227-33.

Sabatine, M. S., Morrow, D. A., Montalescot, G., Dellborg, M., Leiva-Pons, J. L., Keltai, M., Murphy, S. A., McCabe, C. H., Gibson, C. M., Cannon, C. P., Antman, E. M., Braunwald, E. Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial Circulation. 2005;112(25):3846-54.

Gibson, C. M., Ly, H. Q., Murphy, S. A., Ciaglo, L. N., Southard, M. C., Stein, E. B., Buros, J. L., Sabatine, M. S., Cannon, C. P. Usefulness of clopidogrel in abolishing the increased risk of reinfarction associated with higher platelet counts in patients with ST-elevation myocardial infarction (results from CLARITY-TIMI 28) Am J Cardiol. 2006;98(6):761-3.

Kirtane, A. J., Vafai, J. J., Murphy, S. A., Aroesty, J. M., Sabatine, M. S., Cannon, C. P., Gibson, C. M. Angiographically evident thrombus following fibrinolytic therapy is associated with impaired myocardial perfusion in STEMI: a CLARITY-TIMI 28 substudy Eur Heart J. 2006;27(17):2040-5.

Scirica, B. M., Sabatine, M. S., Morrow, D. A., Gibson, C. M., Murphy, S. A., Wiviott, S. D., Giugliano, R. P., McCabe, C. H., Cannon, C. P., Braunwald, E. The role of clopidogrel in early and sustained arterial patency after fibrinolysis for ST-segment elevation myocardial infarction: the ECG CLARITY-TIMI 28 Study J Am Coll Cardiol. 2006;48(1):37-42.

McLean, D. S., Sabatine, M. S., Guo, W., McCabe, C. H., Cannon, C. P. Benefits and risks of clopidogrel pretreatment before coronary artery bypass grafting in patients with ST-elevation myocardial infarction treated with fibrinolytics in CLARITY-TIMI 28 J Thromb Thrombolysis. 2007;24(2):85-91.

Verheugt, F. W., Montalescot, G., Sabatine, M. S., Soulat, L., Lambert, Y., Lapostolle, F., Adgey, J., Cannon, C. P. Prehospital fibrinolysis with dual antiplatelet therapy in ST-elevation acute myocardial infarction: a substudy of the randomized double blind CLARITY-TIMI 28 trial J Thromb Thrombolysis. 2007;23(3):173-9.

Gibson, C. M., Murphy, S. A., Pride, Y. B., Kirtane, A. J., Aroesty, J. M., Stein, E. B., Ciaglo, L. N., Southard, M. C., Sabatine, M. S., Cannon, C. P., Braunwald, E. Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study Am Heart J. 2008;155(1):133-9.

Gibson, C. M., Pride, Y. B., Buros, J. L., Kunadian, V., Southard, M. C., Harrigan, C. J., Ciaglo, L. N., Sabatine, M. S., Cannon, C. P., Braunwald, E. Relation of hyperemic epicardial flow to outcomes among patients with ST-segment elevation myocardial infarction receiving fibrinolytic therapy Am J Cardiol. 2008;101(9):1232-8.

Gibson, C. M., Pride, Y. B., Buros, J. L., Lord, E., Shui, A., Murphy, S. A., Pinto, D. S., Zimetbaum, P. J., Sabatine, M. S., Cannon, C. P., Josephson, M. E. Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction J Am Coll Cardiol. 2008;51(5):546-51.

O'Donoghue, M., Morrow, D. A., Cannon, C. P., Guo, W., Murphy, S. A., Gibson, C. M., Sabatine, M. S. Association between baseline neutrophil count, clopidogrel therapy, and clinical and angiographic outcomes in patients with ST-elevation myocardial infarction receiving fibrinolytic therapy Eur Heart J. 2008;29(8):984-91.

Pinto, D. S., Kirtane, A. J., Pride, Y. B., Murphy, S. A., Sabatine, M. S., Cannon, C. P., Gibson, C. M. Association of blood glucose with angiographic and clinical outcomes among patients with ST-segment elevation myocardial infarction (from the CLARITY-TIMI-28 study) Am J Cardiol. 2008;101(3):303-7.

Pride, Y. B., Buros, J. L., Lord, E., Southard, M. C., Harrigan, C. J., Ciaglo, L. N., Sabatine, M. S., Cannon, C. P., Gibson, C. M. Angiographic perfusion score in patients treated with PCI at late angiography following fibrinolytic administration for ST-segment elevation myocardial infarction is associated with morbidity and mortality at 30 days J Thromb Thrombolysis. 2008;26(2):106-12. Abstract

Sabatine, M. S., Hamdalla, H. N., Mehta, S. R., Fox, K. A., Topol, E. J., Steinhubl, S. R., Cannon, C. P. Efficacy and safety of clopidogrel pretreatment before percutaneous coronary intervention with and without glycoprotein IIb/IIIa inhibitor use Am Heart J. 2008;155(5):910-7.

Sabatine, M. S., Morrow, D. A., Higgins, L. J., MacGillivray, C., Guo, W., Bode, C., Rifai, N., Cannon, C. P., Gerszten, R. E., Lee, R. T. Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction Circulation. 2008;117(15):1936-44.

Berger, J. S., Bhatt, D. L., Cannon, C. P., Chen, Z., Jiang, L., Jones, J. B., Mehta, S. R., Sabatine, M. S., Steinhubl, S. R., Topol, E. J., Berger, P. B. The relative efficacy and safety of clopidogrel in women and men a sex-specific collaborative meta-analysis J Am Coll Cardiol. 2009;54(21):1935-45. Abstract

Desai, N. R., Mega, J. L., Jiang, S., Cannon, C. P., Sabatine, M. S. Interaction between cigarette smoking and clinical benefit of clopidogrel Journal of the American College of Cardiology. 2009;53(15):1273-8. Abstract

Pride, Y. B., Appelbaum, E., Lord, E. E., Sloan, S., Cannon, C. P., Sabatine, M. S., Gibson, C. M. Relation between myocardial infarct size and ventricular tachyarrhythmia among patients with preserved left ventricular ejection fraction following fibrinolytic therapy for ST-segment elevation myocardial infarction Am J Cardiol. 2009;104(4):475-9.

Gibler, K. B., Huskamp, H. A., Sabatine, M. S., Murphy, S. A., Cohen, D. J., Cannon, C. P. Cost-effectiveness analysis of short-term clopidogrel therapy for ST elevation myocardial infarction Crit Pathw Cardiol. 2010;9(1):14-8. Abstract

Harkness, J. R., Sabatine, M. S., Braunwald, E., Morrow, D. A., Sloan, S., Wiviott, S. D., Giugliano, R. P., Antman, E. M., Cannon, C. P., Scirica, B. M. Extent of ST-segment resolution after fibrinolysis adds improved risk stratification to clinical risk score for ST-segment elevation myocardial infarction Am Heart J. 2010;159(1):55-62. Abstract

Ahmed, S., Michael Gibson, C., Cannon, C. P., Murphy, S. A., Sabatine, M. S. Impact of reduced glomerular filtration rate on outcomes in patients with ST-segment elevation myocardial infarction undergoing fibrinolysis: a CLARITY-TIMI 28 analysis J Thromb Thrombolysis. 2011;31(4):493-500. Abstract

Waks, J. W., Sabatine, M. S., Cannon, C. P., Morrow, D. A., Gibson, C. M., Wiviott, S. D., Giugliano, R. P., Sloan, S., Scirica, B. M. Clinical Implications and Correlates of Q Waves in Patients With ST-Elevation Myocardial Infarction Treated With Fibrinolysis: Observations from the CLARITY-TIMI 28 Trial Clin Cardiol. 2014;37(3):160-6. Abstract